Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 9, 2025 • 10:31 PM ET

Date/Time Source News Release
03/13/2025 08:34 AM EDT Business Wire ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025
03/11/2025 04:04 PM EDT Business Wire ChromaDex to Present at the 37th Annual Roth Conference
03/04/2025 04:02 PM EST Business Wire ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results
02/25/2025 04:07 PM EST Business Wire ChromaDex to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 4, 2025
01/06/2025 08:32 AM EST Business Wire ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
12/03/2024 08:34 AM EST Business Wire ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category
11/14/2024 08:32 AM EST Business Wire ChromaDex's Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology's Inaugural Longevity Supplement
11/07/2024 08:32 AM EST Business Wire ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide
10/31/2024 04:04 PM EDT Business Wire ChromaDex Corporation Reports Third Quarter 2024 Financial Results
10/28/2024 08:32 AM EDT Business Wire ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
Page

Additional News

As of June 9, 2025 • 10:31 PM ET

Date/Time Source News Release
04/22/2025 04:46 PM EDT Stock Traders Daily Objective long/short (CDXC) Report
04/06/2025 09:10 AM EDT Stock Traders Daily (CDXC) Trading Advice
03/06/2025 10:30 AM EST SeekingAlpha ChromaDex Capitalizes On Longevity Boom But Valuation Remains High
03/04/2025 08:53 PM EST SeekingAlpha ChromaDex Corporation (CDXC) Q4 2024 Earnings Call Transcript
03/04/2025 05:15 PM EST Zacks ChromaDex (CDXC) Q4 Earnings and Revenues Surpass Estimates
03/04/2025 04:05 PM EST SeekingAlpha ChromaDex GAAP EPS of $0.09 beats by $0.07, revenue of $29.1M beats by $2.59M
03/04/2025 10:00 AM EST SeekingAlpha Here are the major earnings after the close today
03/04/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Tuesday, March 4th, 2025
03/04/2025 04:30 AM EST US Earnings Reports Expected earnings - ChromaDex Corporation
02/20/2025 08:02 AM EST Zacks Pick These 4 Stocks With Solid Net Profit Margin to Boost Return
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.